In-Silico Drug Discovery & Therapeutics Group (IDDTG)

Department of Computational Bioscience and Drug Discovery

Research Group

In-Silico Drug Discovery & Therapeutics Group (IDDTG)

About our group

The In-Silico Drug Discovery & Therapeutics Group (IDDTG) is a multidisciplinary research initiative dedicated to leveraging computational chemistry, bioinformatics, and molecular modeling to accelerate the discovery and development of novel therapeutic agents. By integrating advanced in-silico tools with experimental validation, IDDTG aims to address global health challenges, from infectious diseases and neurological disorders to cancer and metabolic dysfunctions. Our team brings together expertise in organic synthesis, structural biology, pharmacology, and machine learning to design safer, more effective, and targeted therapies. Through collaborations with academic institutions, pharmaceutical industries, and research organizations worldwide, IDDTG is committed to pioneering innovations in modern drug discovery pipelines.

Vision

To become a leading global hub in computational drug discovery and therapeutic innovation, revolutionizing healthcare by developing next-generation medicines through sustainable, precise, and cost-effective in-silico approaches

Mission

To integrate computational chemistry, AI, and molecular modeling in the design of novel drug candidates with high therapeutic potential.
To focus on multidisciplinary research combining organic synthesis, medicinal chemistry, and bioinformatics for accelerated drug discovery.
To develop target-specific therapeutics for combating neurological, infectious, metabolic, and oncological diseases.
To foster international collaborations and industry partnerships that bridge the gap between in-silico predictions and experimental drug development.
To train and mentor the next generation of scientists and researchers in cutting-edge computational and therapeutic approaches.
To contribute towards sustainable and cost-effective healthcare solutions that can benefit both developed and developing nations.